Journal of Diabetes Research / 2015 / Article / Fig 1

Clinical Study

Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study

Figure 1

Effect of bromocriptine-QR therapy on (Panel (a)) and total daily insulin dose (TDID) (Panel (b)) over 24 weeks in subjects on metformin plus high-dose basal-bolus insulin therapy at baseline.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.